21. A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms. (October 2011) Authors: Geissler, Julia; Lesch, Klaus-Peter Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 10(2011) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms. (October 2011) Authors: Geissler, Julia; Lesch, Klaus-Peter Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 10(2011) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. A manic episode in a patient with stable bipolar disorder triggered by intranasal mometasone furoate. (February 2014) Authors: Saraga, Michael Journal: Therapeutic advances in psychopharmacology Issue: Volume 4:Number 1(2014:Feb.) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment. (January 2018) Authors: Drago, Antonio; Kure Fischer, Ellen Journal: International clinical psychopharmacology Issue: Volume 33:Number 1(2018:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. A natural study of the efficacy of replacement medications for the treatment of clozapine-induced hypersalivation. (April 2016) Authors: Chu, Simon; Qurashi, Inti; Campbell, Niall; Stephenson, Paul; Massey, Ruth; Drake, Richard; Husain, Nusrat Journal: Therapeutic advances in psychopharmacology Issue: Volume 6:Number 2(2016:Apr.) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia. (December 2013) Authors: Suzuki, Hidenobu; Gen, Keishi; Takahashi, Yuki Journal: Therapeutic advances in psychopharmacology Issue: Volume 3:Number 6(2013) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series. (December 2013) Authors: Mondal, Somnath; Saha, Indranil; Das, Saibal; Ganguly, Abhrajit; Das, Debasis; Tripathi, Santanu Kumar Journal: Therapeutic advances in psychopharmacology Issue: Volume 3:Number 6(2013) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany. (February 2013) Authors: Flachenecker, Peter Journal: Expert review of neurotherapeutics Issue: Volume 13:Number 3(2013)Supplement 1 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany. (February 2013) Authors: Flachenecker, Peter Journal: Expert review of neurotherapeutics Issue: Volume 13(2013)Supplement 3 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia. (February 2012) Authors: Staner, Luc; Danjou, Philippe; Luthringer, Remy Journal: Expert review of neurotherapeutics Issue: Volume 12:Number 2(2012) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗